ACCENTRIX

Swiss trademark · 515473 · Word mark · In force

Register entry

Registration number
515473
Application number
04954/2003
Status
In force
Type
Word mark
Filed
Sep 29, 2003
Registered
Oct 28, 2003
Published
Nov 11, 2003
Protected until
Sep 29, 2033
Priority
17.04.2003 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Préparations pharmaceutiques pour le traitement des maladies et troubles cardiovasculaires, des maladies et troubles oncologiques, des maladies et troubles immunitaires, des maladies et troubles de l'angiogenèse, des maladies et troubles oculaires, des maladies et troubles inflammatoires.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 8, 2023

    Renewed

    Published in Swissreg on 08.05.2023

  2. Jul 4, 2016

    Holder’s address changed

    Published in Swissreg on 04.07.2016

  3. Oct 29, 2013

    Transferred

    Owner
    GENENTECH, INC., 1 DNA Way, South San Francisco (CA 94080), USA → Novartis AG, 4002 Basel
    Representative
    F. Hoffmann-La Roche AG, Corporate Trademarks, 4002 Basel (removed)

    Published in Swissreg on 29.10.2013

  4. Jul 31, 2013

    Renewed

    Published in Swissreg on 31.07.2013

  5. Mar 10, 2011

    Agent entered

    Representative
    Katzarov S.A., 19, rue des Epinettes, 1227 Genève → F. Hoffmann-La Roche AG, Corporate Trademarks, 4002 Basel

    Published in Swissreg on 10.03.2011

  6. Dec 22, 2003

    LGS

    LGS
    5, Préparations pharmaceutiques pour le traitement des maladies et troubles cardiovasculaires, des maldies et troubles oncologiques, des maladies et troubles immunitaires, des maladies et troubles de l'angiogenèse, des maladies et troubles oculaires, des maladies et troubles inflammatoires. → 5, Préparations pharmaceutiques pour le traitement des maladies et troubles cardiovasculaires, des maladies et troubles oncologiques, des maladies et troubles immunitaires, des maladies et troubles de l'angiogenèse, des maladies et troubles oculaires, des maladies et troubles inflammatoires.
    International classification
    5 → 5

    Published in the SOGC no. 246 of 22.12.2003

  7. Nov 11, 2003

    Registered

    Published in the SOGC no. 217 of 11.11.2003

Parties

Holder

Novartis AG

4002 Basel

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.